Target
Methyl-CpG-binding domain protein 2
Ligand
BDBM50264020
Substrate
n/a
Meas. Tech.
Binding Assay
IC50
1550±n/a nM
Citation
 Nelson, WGYegnasubramanian, SLin, XSpeed, TJReichert, Z Agents for reversing epigenetic silencing of genes US Patent  US9034574 Publication Date 5/19/2015 
Target
Name:
Methyl-CpG-binding domain protein 2
Synonyms:
MBD2 | MBD2_HUMAN | Methyl-CpG binding domain protein 2 | Methyl-CpG-binding domain protein 2 (MBD2)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
43278.74
Organism:
Homo sapiens (Human)
Description:
gi_21595776
Residue:
411
Sequence:
MRAHPGGGRCCPEQEEGESAAGGSGAGGDSAIEQGGQGSALAPSPVSGVRREGARGGGRGRGRWKQAGRGGGVCGRGRGRGRGRGRGRGRGRGRGRPPSGGSGLGGDGGGCGGGGSGGGGAPRREPVPFPSGSAGPGPRGPRATESGKRMDCPALPPGWKKEEVIRKSGLSAGKSDVYYFSPSGKKFRSKPQLARYLGNTVDLSSFDFRTGKMMPSKLQKNKQRLRNDPLNQNKGKPDLNTTLPIRQTASIFKQPVTKVTNHPSNKVKSDPQRMNEQPRQLFWEKRLQGLSASDVTEQIIKTMELPKGLQGVGPGSNDETLLSAVASALHTSSAPITGQVSAAVEKNPAVWLNTSQPLCKAFIVTDEDIRKQEERVQQVRKKLEEALMADILSRAADTEEMDIEMDSGDEA
  
Inhibitor
Name:
BDBM50264020
Synonyms:
CHEMBL489770 | GNF-PF-4773 | N-(4-(pyridin-2-yl)thiazol-2-yl)pyridin-2-amine | TCMDC-124275 | US9034574, I
Type:
Small organic molecule
Emp. Form.:
C13H10N4S
Mol. Mass.:
254.31
SMILES:
N(c1nc(cs1)-c1ccccn1)c1ccccn1
Structure:
Search PDB for entries with ligand similarity: